Walleye Trading LLC Cerus Corp Call Options Transaction History

Walleye Trading LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$4.51 - $6.6 $24,354 - $35,640	-5,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $27,864 - $36,990	5,400 New	5,400 $34,000
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $2,934 - $4,296	-600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.89 - $7.78 $4,134 - $4,668	600 New	600 $4,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $49,305 - $68,875	-9,500 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $33,820 - $54,530	9,500 New	9,500 $52,000
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $34,224 - $48,980	-12,400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $11,100 - $13,650	5,000 Added 67.57%	12,400 $34,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,400	7,400 $19,000

162

143M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $306M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.